Should I buy UiPath stock?

Is UiPath Stock a Good Buy Right Now?

Investors eyeing UiPath (PATH) are faced with a mixed, but generally cautious picture. As of the latest data, 15 Wall Street analysts have weighed in on the robotic process automation (RPA) leader, resulting in a consensus rating of Hold. This means that, on average, experts aren’t urging investors to rush in or bail out.

Breaking it down, only 13% of analysts recommend a Strong Buy, and notably, none classify it as a Buy—suggesting limited enthusiasm among professionals. Meanwhile, a commanding 80% lean toward holding the stock, indicating they see value in staying put rather than making aggressive moves. A small 7% suggest Selling, with no analysts issuing a Strong Sell, which at least signals no widespread pessimism.

UiPath remains a key player in automation, serving enterprises eager to streamline operations. However, the sector is becoming increasingly competitive, and growth has faced headwinds amid tighter corporate spending and cautious digital transformation budgets. While the company continues to innovate and expand its platform, its stock performance has reflected broader market skepticism about near-term profitability.

For individual investors, the analyst split suggests caution. A Hold rating doesn’t mean the stock is doomed—it could still benefit patient investors—but it's unlikely to be a rapid mover. If you already own shares, holding may be a reasonable strategy. For new investors, it might be wise to wait for clearer signs of revenue acceleration or a more attractive entry point.

Ultimately, while UiPath still holds strategic importance in enterprise software, the current consensus says: watch closely, but don’t rush.